1/5
04:01 pm
glpg
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
Low
Report
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
12/30
01:07 am
glpg
Low
Report
12/22
05:42 am
glpg
Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation [Seeking Alpha]
Low
Report
Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation [Seeking Alpha]
12/22
01:07 am
glpg
Galapagos (NASDAQ:GLPG) was downgraded by analysts at
Wall Street Zen
Low
Report
12/18
04:36 pm
glpg
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus [Yahoo! Finance]
Medium
Report
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus [Yahoo! Finance]
12/18
04:01 pm
glpg
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Medium
Report
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
12/14
01:26 am
glpg
Low
Report
12/8
01:30 am
glpg
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
Low
Report
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
11/26
06:04 am
glpg
Galapagos (NASDAQ:GLPG) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating on the stock.
Low
Report
Galapagos (NASDAQ:GLPG) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating on the stock.
11/26
01:30 am
glpg
Galapagos Receives Transparency Notifications from Bank of America
Low
Report
Galapagos Receives Transparency Notifications from Bank of America
11/23
02:11 am
glpg
Low
Report
11/7
02:22 pm
glpg
Galapagos (NASDAQ:GLPG) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $32.00. They now have a "sector perform" rating on the stock.
Low
Report
Galapagos (NASDAQ:GLPG) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $32.00. They now have a "sector perform" rating on the stock.
11/5
04:01 pm
glpg
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update
Medium
Report
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update
11/3
04:01 pm
glpg
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
Low
Report
Galapagos to Present New Data from Cell Therapy Program at ASH 2025